Macrophages Reprogrammed In Vitro Towards the M1 Phenotype and Activated with LPS Extend Lifespan of Mice with Ehrlich Ascites Carcinoma

Abstract

BackgroundThe majority of tumors trigger macrophage reprogramming from an anti-tumor M1 phenotype towards a pro-tumor M2 phenotype. The M2 phenotype promotes tumor growth. We hypothesized that increasing the number of M1 macrophages in a tumor would limit carcinogenesis and extend the lifespan of the tumor host. The aim of this study was to verify this hypothesis in Ehrlich ascites carcinoma (EAC). The objectives were to evaluate effects of 1) EAC on a macrophage phenotype and NO-producing macrophage activity in vivo; 2) ascitic fluid from mice with EAC on a macrophage phenotype and NO-producing macrophage activity in vitro; and 3) in vitro reprogrammed M1 macrophages on lifespan of mice with EAC.Material/MethodsThe study was conducted using C57BL/6J mice.ResultsConcentration of nitrite, a stable NO metabolite and an index of NO production, was measured spectrophotometrically. Shifts of macrophage phenotype were assessed by changes in NO production as well as by amounts of CD80, a marker of M1 phenotype, and CD206, a marker of M2 phenotype. The CD markers were measured by flow cytometry. Macrophages were reprogrammed towards the M1 phenotype using two reprogramming factors: 0% FBS and 20 ng/ml IFN-γ. The study results showed that 1) EAC inhibited the macrophage NO production in vivo and reprogrammed macrophages towards the M2 phenotype; 2) ascitic fluid of mice with EAC inhibited the macrophage NO production in vitro and reprogrammed macrophages towards the M2 phenotype; and 3) injection of in vitro reprogrammed M1 macrophages into mice with EAC significantly increased the lifespan of mice.ConclusionsThese findings suggest that promising biotechnologies for restriction of tumor growth could be developed based on the in vitro macrophage reprogramming.

Ceramide and palmitic acid inhibit macrophage-mediated epithelial–mesenchymal transition in colorectal cancer

“…Unlike stably differentiated cells, M1 and M2 macrophages can switch phenotypes [23][24][25]. Thus, reprogramming M2 TAMs towards the immunogenic M1 phenotype in vivo to block tumor progression could be a promising strategy for the treatment of cancers.…”

Cellular study of the LPS‐induced osteoclastic multinucleated cell formation from RAW264.7 cells

“…For instance, previous study demonstrated LPS‐induced osteoclastic multinucleated cell formation through the SAPK/JNK pathway (Islam et al, ). Another study showed LPS as one of key stimuli that could stimulate macrophages M1 polarization by the effect of AP‐1 (Al Faraj et al, ; Kalish et al, ). Thus, we speculated that the two transcription factors c‐Fos and Nfatc1 are involved in the LPS‐induced osteoclastogenesis in RAW264.7 cells.…”

Androgen-Influenced Polarization of Activin A-Producing Macrophages Accompanies Post-pyelonephritic Renal Scarring

“…Macrophage recruitment, polarization, and function are important for the proper resolution of many bacterial infections. In a typical response, circulating monocytes are recruited to the site of infection upon signaling by damage-associated and pathogen-associated molecular patterns (DAMPs and PAMPs), and proinflammatory cytokines such as IL-6, IFNγ, and TNFα; these arriving monocytes initially differentiate, or polarize, toward proinflammatory (M1) macrophages (17)(18)(19)(20)(21)(22)(23)(24)(25). These M1 cells further secrete proinflammatory cytokines and chemokines, exert phagocytic activity, and induce neutrophil apoptosis (25)(26)(27)(28)(29)(30).…”